← FDA DRUG APPROVALS

FDA ANDA · ANDA062993

ERYTHROMYCIN LACTOBIONATE

Sponsor: BAXTER HLTHCARE

APPLICATION
ANDA062993
TYPE
ANDA
ORIGINAL APPROVAL
1989-05-09
LATEST ACTION
1996-05-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ERYTHROMYCIN LACTOBIONATEDiscontinued
ERYTHROMYCIN LACTOBIONATE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
ERYTHROMYCIN LACTOBIONATEDiscontinued
ERYTHROMYCIN LACTOBIONATE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1996-05-10Labeling · Supplement 4AP
1993-03-26Labeling · Supplement 3AP
1992-10-30Manufacturing (CMC) · Supplement 2AP
1989-05-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →